These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4036017)

  • 21. [Clinico-cytological comparisons in chronic glomerulonephritis with kidney function disorder].
    Pluzhnik EG
    Ter Arkh; 1982; 54(7):70-2. PubMed ID: 7135228
    [No Abstract]   [Full Text] [Related]  

  • 22. [The serum magnesium level in kidney diseases].
    Klete H
    Z Gesamte Inn Med; 1967 Dec; 22(23):756-62. PubMed ID: 5590637
    [No Abstract]   [Full Text] [Related]  

  • 23. [Variants in the transient deterioration of kidney function in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1996; 68(11):62-7. PubMed ID: 9045385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal dysfunction in chronic glomerulonephritis and its diagnostic significance].
    Ratner MIa; Brodskiĭ MA
    Klin Med (Mosk); 1981 Jul; 59(7):56-63. PubMed ID: 7278100
    [No Abstract]   [Full Text] [Related]  

  • 25. [Disorders of renal tubular functions in chronic glomerulonephritis and pyelonephritis].
    Ovezov BO
    Urol Nefrol (Mosk); 1968; 33(3):8-13. PubMed ID: 5669805
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methods of detecting the character of renal dysfunction and types of renal function disorders in chronic glomerulonephritis without renal insufficiency].
    Ratner MIa; Tomilina NA; Ovezov BO; Demina VG
    Sov Med; 1971; 34(3):18-23. PubMed ID: 5116861
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of biopsy an partial kidney function data in chronic glomerulonephritis].
    Ratner NA; Vikhert AM; Kramer AA; aĭkova DA; Kul'dova SKh
    Klin Med (Mosk); 1970 Jul; 48(7):25-33. PubMed ID: 5494090
    [No Abstract]   [Full Text] [Related]  

  • 28. [The clinical significance of renal functional reserve].
    Zverev KV; Kutyrina IM; Gersimenko OI
    Klin Med (Mosk); 1995; 73(3):99-102. PubMed ID: 8577129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excretion of epidermal growth factor in human adult polycystic kidney disease.
    Weinstein T; Hwang D; Lev-Ran A; Ori Y; Korzets A; Levi J
    Isr J Med Sci; 1997 Oct; 33(10):641-2. PubMed ID: 9397135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognosis of chronic glomerulonephritis. (Report on 298 cases)].
    Legrain M; Beauflis H; Guedon J
    Z Urol Nephrol; 1978 Jul; 71(7):445-54. PubMed ID: 696019
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems of pregnancy in glomerulonephritis].
    Abe S
    Nihon Rinsho; 1988 Jun; 46(6):1419-23. PubMed ID: 3418915
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic use of ultrasound in certain chronic kidney diseases].
    Shultsev GP; Speranskiĭ AP; Khanukaeva RM
    Ter Arkh; 1974; 46(3):129-36. PubMed ID: 4828491
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigations on pathogenesis of hyperchloremic acidosis in chronic renal diseases.
    Raszeja-Wanic B; Jasiński K; Szereszewska H
    Pol Med J; 1968; 7(6):1363-70. PubMed ID: 5719284
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sanatorium treatment of patients with chronic glomerulonephritis (without disorder of the nitrogen excretory function of the kidneys) on the Crimean South Shore].
    Pyrig LA; Ratner ZG; Kropacheva NA; Vinnikova FIa; Oleĭnikov PD; Povetkin SV
    Vrach Delo; 1968 Jul; 7():44-7. PubMed ID: 4245750
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of renoparenchymal hypertension in chronic glomerulonephritis with normal and impaired renal function].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):49-53. PubMed ID: 7164406
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of mineral water from the Naftusia spa of the Truskavets health resort on the functional state of the kidneys in chronic diffuse glomerulonephritis].
    Dudchenko MA; Andreeva ME; Chuenko AE; Dudchenko AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):529-31. PubMed ID: 5317697
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of cardiac output in the development of the hypertensive syndrome in chronic parenchymal diseases of the kidneys].
    Sumarokov AV; Mikhaĭlov AA; Danil'chenko MA
    Kardiologiia; 1971 Oct; 11(10):65-9. PubMed ID: 4944891
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
    Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.